JP Morgan Chase’s ImageneBio Inc IMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47K Buy
293
+223
+319% +$1.45K ﹤0.01% 7078
2025
Q4
$483 Hold
70
﹤0.01% 7083
2025
Q3
$571 Sell
70
-1
-1% -$13 ﹤0.01% 7041
2025
Q2
$1.14K Hold
71
﹤0.01% 6608
2025
Q1
$1.09K Sell
71
-12,907
-99% -$223K ﹤0.01% 6620
2024
Q4
$255K Buy
12,978
+12,907
+18,179% +$261K ﹤0.01% 5371
2024
Q3
$1.47K Hold
71
﹤0.01% 6672
2024
Q2
$1.4K Sell
71
-1,041
-94% -$18.4K ﹤0.01% 6571
2024
Q1
$18.9K Sell
1,112
-749
-40% -$13.6K ﹤0.01% 6238
2023
Q4
$44K Buy
1,861
+488
+36% +$15.9K ﹤0.01% 6040
2023
Q3
$71.3K Sell
1,373
-112
-8% -$6.74K ﹤0.01% 5671
2023
Q2
$117K Buy
1,485
+1,412
+1,934% +$101K ﹤0.01% 5396
2023
Q1
$3K Hold
73
﹤0.01% 6345
2022
Q4
$2K Sell
73
-131
-64% -$4.19K ﹤0.01% 6315
2022
Q3
$9K Buy
204
+89
+77% +$5.15K ﹤0.01% 5986
2022
Q2
$6K Sell
115
-1,316
-92% -$72.6K ﹤0.01% 6121
2022
Q1
$104K Buy
1,431
+290
+25% +$30.8K ﹤0.01% 5489
2021
Q4
$172K Buy
1,141
+809
+244% +$131K ﹤0.01% 5436
2021
Q3
$50K Buy
332
+42
+14% +$6.1K ﹤0.01% 5842
2021
Q2
$49K Buy
+290
New +$64K ﹤0.01% 5738

Other funds holding IMA

JP Morgan Chase's IMA Position: Q1 2026 in Review

JP Morgan Chase increased its ImageneBio Inc (IMA) stake by 319% in Q1 2026, buying an estimated $1.45K and bringing the position to 293 shares worth $1.47K. The position accounts for ﹤0.01% of the portfolio, ranked #7078.

JP Morgan Chase first reported a position in IMA in Q2 2021 and has held it in 20 quarters since. The position peaked at $255K in Q4 2024. 39 funds tracked by Wall St. Rank hold IMA as of Q1 2026.

  • JP Morgan Chase held 293 shares of ImageneBio Inc worth $1.47K as of Q1 2026.
  • JP Morgan Chase bought 223 ImageneBio Inc shares in Q1 2026, an estimated $1.45K.
  • ImageneBio Inc made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7078 holding.
  • JP Morgan Chase first reported a position in ImageneBio Inc in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's ImageneBio Inc position peaked at $255K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.